Lipoperoxide Nanoemulsion as Adjuvant in Cisplatin Cancer Therapy: In Vitro Study on Human Colon Adenocarcinoma DLD-1 Cells

Cisplatin is a first-choice chemotherapeutic agent used to treat solid tumors even though the onset of multi-drug resistance and the time–dose side-effects impair its mono-therapeutic application. Therefore, new drug-delivery approaches, based on nanomedicine strategies, are needed to enhance its th...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernazza, Stefania, Dellacasa, Elena, Tirendi, Sara, Pastorino, Laura, Bassi, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224288/
https://www.ncbi.nlm.nih.gov/pubmed/34064174
http://dx.doi.org/10.3390/nano11061365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224288/
https://www.ncbi.nlm.nih.gov/pubmed/34064174
http://dx.doi.org/10.3390/nano11061365

Ejemplares similares